DecisionPoint Financial’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.7K Sell
122
-15
-11% -$1.73K ﹤0.01% 161
2025
Q4
$14.4K Buy
137
+125
+1,042% +$11.7K ﹤0.01% 166
2025
Q3
$1.08K Sell
12
-1,000
-99% -$82.4K ﹤0.01% 314
2025
Q2
$82.8K Buy
1,012
+12
+1% +$954 0.02% 68
2025
Q1
$89.8K Hold
1,000
0.03% 60
2024
Q4
$99.5K Hold
1,000
0.03% 58
2024
Q3
$114K Hold
1,000
0.04% 48
2024
Q2
$113K Hold
1,000
0.04% 47
2024
Q1
$131K Hold
1,000
0.05% 43
2023
Q4
$109K Hold
1,000
0.05% 41
2023
Q3
$103K Hold
1,000
0.05% 35
2023
Q2
$115K Hold
1,000
0.06% 33
2023
Q1
$106K Hold
1,000
0.06% 35
2022
Q4
$111K Buy
+1,000
New +$102K 0.07% 32

Other funds holding MRK

DecisionPoint Financial's MRK Position: Q1 2026 in Review

DecisionPoint Financial reduced its Merck (MRK) stake by 11% in Q1 2026, selling an estimated $1.73K and leaving 122 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #161.

DecisionPoint Financial first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $131K in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • DecisionPoint Financial held 122 shares of Merck worth $14.7K as of Q1 2026.
  • DecisionPoint Financial sold 15 Merck shares in Q1 2026, an estimated $1.73K.
  • Merck made up ﹤0.01% of DecisionPoint Financial's portfolio in Q1 2026, its #161 holding.
  • DecisionPoint Financial first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • DecisionPoint Financial's Merck position peaked at $131K in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on DecisionPoint Financial's 13F filing for Q1 2026, filed 6 May 2026.